Cargando…
Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study
BACKGROUND: Anti‐cancer vascular endothelial growth factor inhibitors (VEGFI) frequently induce a rise in blood pressure (BP). The most effective treatment of this BP rise is currently unknown, and risk factors and its association with survival remain inconclusive. METHODS AND RESULTS: Baseline char...
Autores principales: | van Dorst, Daan C. H., Kabadayi, Sumeyye, Oomen‐de Hoop, Esther, Danser, A.H. Jan, Mathijssen, Ron H. J., Versmissen, Jorie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973592/ https://www.ncbi.nlm.nih.gov/pubmed/36583425 http://dx.doi.org/10.1161/JAHA.122.028050 |
Ejemplares similares
-
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
por: van Doorn, Leni, et al.
Publicado: (2022) -
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
por: van Dorst, Daan C.H., et al.
Publicado: (2021) -
Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors
por: van Eerden, Ruben A. G., et al.
Publicado: (2021) -
Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2019) -
Vascular medicine and cardio-oncology – A new, evolving clinical frontier
por: Versmissen, Jorie, et al.
Publicado: (2020)